FDA Inspection 1271024 — Labcorp Central Laboratory Services Limited Partnership
The FDA completed an inspection of Labcorp Central Laboratory Services Limited Partnership on May 1, 2025 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 1, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Indianapolis, IN (United States)
Additional Details
Sponsor, Contract Research Organization